IndianaCancer clinical trial program.
What it does
Allows an organization or entity to establish and administer a cancer clinical trial participation program for the purpose of providing payments to a participant for certain costs incurred by the participant while participating in a cancer clinical trial. Sets forth program requirements and participant eligibility.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2025
- Apr 3Signed by the Governor Mike BraunBecame Law
- Apr 3Public Law 29Major
- Mar 27Signed by the President of the SenateMajor
- Mar 24Signed by the President Pro TemporeMajor
- Mar 20Signed by the SpeakerMajor
- Mar 19Returned to the House without amendmentsMinor
- Mar 18Third reading: passed; Roll Call 242: yeas 49, nays 0Passed Senate
- Vote recorded HB 1065 - Charbonneau - 3rd Reading. Result: pass.Upper
- Mar 18Senator Randolph added as cosponsor
- Mar 17Second reading: ordered engrossedMinor
- Mar 13Committee report: do pass, adoptedMinor
- Mar 3First reading: referred to Committee on Health and Provider ServicesMinor
- Feb 18Referred to the SenateMinor
- Feb 17Representatives Barrett, Aylesworth, Porter added as coauthors
- Vote recorded HB 1065 - Shackleford - 3rd Reading. Result: pass.Lower
- Feb 17Cosponsor: Senator Jackson L
- Feb 17Representative Aylesworth removed as coauthor
- Feb 17Third reading: passed; Roll Call 166: yeas 95, nays 0Passed House
- Feb 17Senate sponsors: Senators Charbonneau, Crider, Yoder
- Feb 13Second reading: ordered engrossedMinor
- Feb 11Committee report: amend do pass, adoptedMinor
- Jan 27Representative Aylesworth added as coauthor
- Jan 8Authored by Representative Shackleford
- Jan 8First reading: referred to Committee on Public HealthIntroduced